Page last updated: 2024-08-23

pregnanolone and Depressive Disorder, Treatment-Resistant

pregnanolone has been researched along with Depressive Disorder, Treatment-Resistant in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Cristea, IA; Naudet, F1
Daly, EJ; Drevets, WC; Fedgchin, M; Hough, D; Mathews, M; Popova, V; Singh, JB1
Cusin, C; Dichtel, LE; Dording, C; Fava, M; Fisher, LB; Kimball, AS; Miller, KK; Mischoulon, D; Nyer, M; Pedrelli, P; Rao, EM; Shapero, BG1
Kleinman, RA; Schatzberg, AF1

Trials

1 trial(s) available for pregnanolone and Depressive Disorder, Treatment-Resistant

ArticleYear
Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.
    The Journal of clinical psychiatry, 2020, 06-09, Volume: 81, Issue:4

    Topics: Aged; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; GABA Modulators; Humans; Middle Aged; Pilot Projects; Postmenopause; Pregnanolone; Treatment Outcome

2020

Other Studies

3 other study(ies) available for pregnanolone and Depressive Disorder, Treatment-Resistant

ArticleYear
US Food and Drug Administration approval of esketamine and brexanolone.
    The lancet. Psychiatry, 2019, Volume: 6, Issue:12

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Depressive Disorder, Treatment-Resistant; Drug Combinations; Female; Humans; Ketamine; Pregnanolone; United States; United States Food and Drug Administration

2019
Approval of esketamine for treatment-resistant depression.
    The lancet. Psychiatry, 2020, Volume: 7, Issue:3

    Topics: beta-Cyclodextrins; Depression; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Ketamine; Pregnanolone; United States; United States Food and Drug Administration

2020
Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
    The American journal of psychiatry, 2021, 03-01, Volume: 178, Issue:3

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Neurosteroids; Pregnanes; Pregnanolone; Pyrazoles

2021